Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

Similar articles for PubMed (Select 6463598)

2.

Thiazide prophylaxis of urolithiasis. A double-blind study in general practice.

Laerum E, Larsen S.

Acta Med Scand. 1984;215(4):383-9.

PMID:
6375276
3.

[Treatment of hypercalciuria found in urolithiasis patients].

Yamaguchi K, Miyauchi T, Usui T, Murakami M, Ito H, Shimazaki J.

Hinyokika Kiyo. 1985 Jan;31(1):17-22. Japanese.

PMID:
3993493
4.

Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis.

Höbarth K, Hofbauer J, Szabo N.

Urology. 1994 Jul;44(1):20-4; discussion 24-5.

PMID:
8042263
6.

Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria.

Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H.

Br J Urol. 1992 Jun;69(6):571-6.

PMID:
1638340
7.

Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.

Ceylan K, Topal C, Erkoc R, Sayarlioglu H, Can S, Yilmaz Y, Dogan E, Algun E, Gonulalan H.

Ann Pharmacother. 2005 Jun;39(6):1034-8. Epub 2005 Apr 19.

PMID:
15840731
8.

Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones.

Ala-Opas M, Elomaa I, Porkka L, Alfthan O.

Scand J Urol Nephrol. 1987;21(4):311-4.

PMID:
2832935
9.

Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients.

Ebisuno S, Morimoto S, Yasukawa S, Ohkawa T.

Br J Urol. 1991 Mar;67(3):237-40.

PMID:
1902388
10.

[Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].

Musialik D, Głuszek J, Pieczyńska A.

Pol Tyg Lek. 1991 Oct 7-21;46(40-42):739-42. Polish.

PMID:
1669148
11.

Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.

Nishiura JL, Campos AH, Boim MA, Heilberg IP, Schor N.

Urol Res. 2004 Oct;32(5):362-6. Epub 2004 Jun 19.

PMID:
15221244
12.
13.

Urine composition in patients with urolithiasis during treatment with magnesium oxide.

Tiselius HG, Ahlstrand C, Larsson L.

Urol Res. 1980;8(4):197-206.

PMID:
7222314
14.

[Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria].

Kurita Y, Kageyama S, Ishikawa A, Ushiyama T, Ohta N, Suzuki K, Kawabe K.

Hinyokika Kiyo. 1994 Jun;40(6):479-83. Japanese.

PMID:
8073954
15.

Enhancement of renal excretion of uric acid during long-term thiazide therapy.

Pak CY, Tolentino R, Stewart A, Galosy RA.

Invest Urol. 1978 Nov;16(3):191-3.

PMID:
711411
16.
17.

Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.

Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I.

Urol Res. 2008 Dec;36(6):303-7. doi: 10.1007/s00240-008-0161-5. Epub 2008 Nov 5.

PMID:
18985334
19.

Screening for biochemical abnormalities in urolithiasis patients.

Orakzai N, Hanbury DC, Farrington K.

J Ayub Med Coll Abbottabad. 2004 Apr-Jun;16(2):60-3.

PMID:
15455621
20.

Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.

Fuselier HA, Moore K, Lindberg J, Husserl FE, Cole FE, Kok DJ, Whitehead D, Galliano DJ, Erwin DT.

Urology. 1998 Dec;52(6):988-94.

PMID:
9836542
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk